TITLE

Correction: Review

PUB. DATE
January 2010
SOURCE
CMAJ: Canadian Medical Association Journal;1/12/2010, Vol. 182 Issue 1, p65
SOURCE TYPE
Academic Journal
DOC. TYPE
Correction notice
ABSTRACT
A correction to the article "Management of Asthma in Adults," that was published in the December 8, 2009 issue is presented.
ACCESSION #
47771952

 

Related Articles

  • Use of sequential quadrupling dose regimens to study efficacy of inhaled corticosteroids in asthma. Phillips K; Oborne J; Harrison T W; Tattersfield A E // Thorax;Jan2004, Vol. 59 Issue 1, p21 

    BACKGROUND: Inhaled corticosteroids are widely used to treat asthma. There is a need to be able to compare different inhaled corticosteroids and different doses of an inhaled corticosteroid to determine potency and dose equivalence, but measuring efficacy in a dose related manner is difficult...

  • Cut steroid use in asthma patients. Dragon, Natalie // GP: General Practitioner;5/26/2003, p8 

    According to a study conducted in Great Britain, decreasing the dose of inhaled steroids does not worsen control among patients with chronic stable asthma. Researchers from the University of Glasgow found that reducing the dose by up to a half reduced the risk of side-effects without...

  • Save your sprays. Wolfe, Yun Lee // Prevention;Jan97, Vol. 49 Issue 1, p52 

    Focuses on a study that examined the difference between scheduled versus as-needed use of albuterol inhaler sprays. The benefit of as-needed use of the asthma medication; The guidelines for those people with mild asthma; The research of Jeffrey M. Drazen and associates as reported in the...

  • Stepping Up Therapy Helps Kids with Uncontrolled Asthma.  // AARC Times;Jun2010, Vol. 34 Issue 6, p73 

    The article presents a study which shows that children who continue to have symptoms of asthma while using low-dose inhaled corticosteroids could benefit by duplicating the dosage of adding leukotriene receptor antagonist (LTRA) or long-acting beta antagonist (LABA) to the inhaled corticosteroid...

  • `Chronotherapy' aims to put drugs on board when they are most needed.  // Modern Medicine;May96, Vol. 64 Issue 5, p21 

    Reports on the effectiveness of chronotherapy, a system in which a patient's dosing schedule is timed to coincide with the period in which the disease strongly manifest itself. Problems with the dosing patterns of current antihypertensives; Use of chronotherapy in asthma patients.

  • Brown Norway Rat Asthma Model of Diphenylmethane-4,4-Diisocyanate (MDI): Analysis of the Elicitation Dose-Response Relationship.  // Toxicological Sciences;Aug2008, Vol. 104 Issue 2, p320 

    The known human asthmagen polymeric diphenylmethane-diisocyanate (MDI) was investigated in the Brown Norway rat skin asthma model. Two types of dose-response relationships are addressed with the following focus: (1) does sensitization dose and surface area influence the subsequent elicitation...

  • Case studies illustrating the implementation of treatment strategies for acute and chronic asthma. Schreck, David M.; Williams, Dennis M. // American Journal of Health-System Pharmacy;5/15/2006, Vol. 63 Issue 10, pS22 

    Purpose. Considerations that enter into decisions about treatment strategies for acute and chronic asthma are illustrated in two case studies. Summary. A patient's signs, symptoms, vital signs, laboratory test results, recent history of illness or exposure to substances that can provoke asthma...

  • LEUKOTRIENE MODIFIERS.  // Complete Guide to Prescription & Nonprescription Drugs 2012;2012, p490 

    The article presents information on leukotriene modifiers for treatment of asthma, including their dosage, usage, adverse reactions or side effects, precautions when administering, and possible interaction with other drugs and substances.

  • UR-60427, a novel H4 receptor-inverse agonist that shows good efficacy in a rat asthma model. Alfón, J.; Ardanaz, N.; Gil-Torregrosa, B.; Fernández, A.; Balsa, D.; Carceller, E.; Gómez, Ll.; Merlos, M.; Cortijo, J.; Morcillo, E.; Bartrolí, X. // Inflammation Research;Mar2010, Vol. 59, p199 

    The article discusses UR-60427, a novel H4 receptor-inverse agonist investigated at Palau Pharma and found to show good efficacy in the rat asthma model. It details that the effects of histamine as full agonist and thioperamide as inverse agonist were compared. The article concludes that the rat...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics